Effectiveness of switching endoscopists for repeat surveillance colonoscopy: a retrospective study.


Journal

BMC gastroenterology
ISSN: 1471-230X
Titre abrégé: BMC Gastroenterol
Pays: England
ID NLM: 100968547

Informations de publication

Date de publication:
06 Oct 2023
Historique:
received: 30 05 2023
accepted: 27 09 2023
medline: 1 11 2023
pubmed: 7 10 2023
entrez: 6 10 2023
Statut: epublish

Résumé

Surveillance colonoscopy decreases colorectal cancer mortality; however, lesions are occasionally missed. Although an appropriate surveillance interval is indicated, variations may occur in the methods used, such as scope manipulation or observation. Therefore, individual endoscopists may miss certain areas. This study aimed to verify the effectiveness of performing repeat colonoscopies with a different endoscopist from the initial procedure. We retrospectively reviewed a database of 8093 consecutive colonoscopies performed in the Omori Red Cross Hospital from January 1st 2018 to June 30th 2021. Data from repeat total colonoscopies performed within three months were collected to assess missed lesions. The patients were divided into two groups according to whether the two examinations were performed by different endoscopists (group D) or the same endoscopist (group S). The primary outcome in both groups was the missed lesion detection rate (MLDR). Overall, 205 eligible patients were analyzed. In total, 102 and 103 patients were enrolled in groups D and S, respectively. The MLDR was significantly higher in group D (61.8% vs. 31.1%, P < 0.0001). Multivariate logistic regression analysis for the detection of missed lesions identified performance by the different endoscopists (odds ratio, 3.38; 95% CI, 1.81-6.30), and sufficient withdrawal time (> 6 min) (odds ratio, 3.10; 95% CI, 1.12-8.61) as significant variables. Overall, our study showed a significant improvement in the detection of missed lesions when performed by different endoscopists. When performing repeat colonoscopy, it is desirable that a different endoscopist perform the second colonoscopy. This study was approved by the Institutional Review Board of the Omori Red Cross Hospital on November 28, 2022 (approval number:22-43).

Sections du résumé

BACKGROUND BACKGROUND
Surveillance colonoscopy decreases colorectal cancer mortality; however, lesions are occasionally missed. Although an appropriate surveillance interval is indicated, variations may occur in the methods used, such as scope manipulation or observation. Therefore, individual endoscopists may miss certain areas. This study aimed to verify the effectiveness of performing repeat colonoscopies with a different endoscopist from the initial procedure.
METHODS METHODS
We retrospectively reviewed a database of 8093 consecutive colonoscopies performed in the Omori Red Cross Hospital from January 1st 2018 to June 30th 2021. Data from repeat total colonoscopies performed within three months were collected to assess missed lesions. The patients were divided into two groups according to whether the two examinations were performed by different endoscopists (group D) or the same endoscopist (group S). The primary outcome in both groups was the missed lesion detection rate (MLDR).
RESULTS RESULTS
Overall, 205 eligible patients were analyzed. In total, 102 and 103 patients were enrolled in groups D and S, respectively. The MLDR was significantly higher in group D (61.8% vs. 31.1%, P < 0.0001). Multivariate logistic regression analysis for the detection of missed lesions identified performance by the different endoscopists (odds ratio, 3.38; 95% CI, 1.81-6.30), and sufficient withdrawal time (> 6 min) (odds ratio, 3.10; 95% CI, 1.12-8.61) as significant variables.
CONCLUSIONS CONCLUSIONS
Overall, our study showed a significant improvement in the detection of missed lesions when performed by different endoscopists. When performing repeat colonoscopy, it is desirable that a different endoscopist perform the second colonoscopy.
TRIAL REGISTRATION BACKGROUND
This study was approved by the Institutional Review Board of the Omori Red Cross Hospital on November 28, 2022 (approval number:22-43).

Identifiants

pubmed: 37803276
doi: 10.1186/s12876-023-02981-3
pii: 10.1186/s12876-023-02981-3
pmc: PMC10557195
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

347

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

Gastroenterology. 2020 Oct;159(4):1252-1261.e5
pubmed: 32562721
Am J Gastroenterol. 1999 Jan;94(1):194-9
pubmed: 9934755
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Eur J Gastroenterol Hepatol. 2020 Apr;32(4):467-474
pubmed: 31834052
Endosc Int Open. 2020 Dec;8(12):E1732-E1740
pubmed: 33269304
Gastrointest Endosc. 2017 Jun;85(6):1273-1280
pubmed: 27931951
Am J Surg. 2022 Mar;223(3):500-502
pubmed: 34916039
Medicine (Baltimore). 2018 Sep;97(38):e12297
pubmed: 30235675
Am J Gastroenterol. 2016 May;111(5):723-9
pubmed: 26809333
Gastrointest Endosc. 2014 Aug;80(2):269-76
pubmed: 24629422
Gastrointest Endosc. 2017 Oct;86(4):724-730
pubmed: 28286095
Dig Endosc. 2021 May;33(4):486-519
pubmed: 33713493
Gastroenterology. 2019 May;156(6):1661-1674.e11
pubmed: 30738046
Gastrointest Endosc. 2009 Mar;69(3 Pt 2):620-5
pubmed: 19136102
Am J Gastroenterol. 2006 Feb;101(2):343-50
pubmed: 16454841
Am J Gastroenterol. 2011 Jun;106(6):1070-4
pubmed: 21326224
Gastroenterology. 2009 Mar;136(3):832-41
pubmed: 19171141
J Gen Intern Med. 2015 Mar;30(3):277-83
pubmed: 25266407
Clin Gastroenterol Hepatol. 2010 Oct;8(10):858-64
pubmed: 20655393
Eur J Gastroenterol Hepatol. 2016 Dec;28(12):1400-1406
pubmed: 27769078
Cancer Med. 2021 Oct;10(20):7184-7193
pubmed: 34477306
Endoscopy. 2018 Jul;50(7):701-707
pubmed: 29415286
JAMA Netw Open. 2022 Aug 1;5(8):e2229538
pubmed: 36044211
Gastrointest Endosc. 2020 Sep;92(3):723-730
pubmed: 32502550
N Engl J Med. 2006 Dec 14;355(24):2533-41
pubmed: 17167136
Endoscopy. 2017 Feb;49(2):186-190
pubmed: 27842422
N Engl J Med. 2012 Feb 23;366(8):687-96
pubmed: 22356322
Am J Gastroenterol. 2011 Aug;106(8):1466-71
pubmed: 21502998
Middle East J Dig Dis. 2015 Oct;7(4):214-9
pubmed: 26609349
N Engl J Med. 2014 Apr 3;370(14):1298-306
pubmed: 24693890
Surg Endosc. 2016 May;30(5):1796-803
pubmed: 26198158

Auteurs

Naoya Okada (N)

Department of Gastroenterology, Omori Red Cross Hospital, 4‑30‑1, Chuo, Ota-Ku, Tokyo, 143‑8527, Japan.
Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Japan.

Jun Arimoto (J)

Department of Gastroenterology, Omori Red Cross Hospital, 4‑30‑1, Chuo, Ota-Ku, Tokyo, 143‑8527, Japan.

Takanori Nishiguchi (T)

Department of Gastroenterology, Omori Red Cross Hospital, 4‑30‑1, Chuo, Ota-Ku, Tokyo, 143‑8527, Japan.

Mikio Kobayashi (M)

Department of Gastroenterology, Omori Red Cross Hospital, 4‑30‑1, Chuo, Ota-Ku, Tokyo, 143‑8527, Japan.

Toshihiro Niikura (T)

Department of Gastroenterology, Omori Red Cross Hospital, 4‑30‑1, Chuo, Ota-Ku, Tokyo, 143‑8527, Japan.

Hiroki Kuwabara (H)

Department of Gastroenterology, Omori Red Cross Hospital, 4‑30‑1, Chuo, Ota-Ku, Tokyo, 143‑8527, Japan.

Michiko Nakaoka (M)

Department of Gastroenterology, Omori Red Cross Hospital, 4‑30‑1, Chuo, Ota-Ku, Tokyo, 143‑8527, Japan.

Atsushi Nakajima (A)

Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Japan.

Hideyuki Chiba (H)

Department of Gastroenterology, Omori Red Cross Hospital, 4‑30‑1, Chuo, Ota-Ku, Tokyo, 143‑8527, Japan. h.chiba04@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH